Mannitol (Intravenous Route)
Name: Mannitol (Intravenous Route)
US Brand Name
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of mannitol injection in children. However, children younger than 2 years of age, especially preterm and term neonates, are more likely to have fluid and electrolyte abnormalities. Safety and efficacy have been established.
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of prochlorperazine in the elderly. However, elderly patients are more likely to have fluid and electrolyte imbalances and age-related kidney, heart, or lung problems, which may require caution in the dose for patients receiving this medicine.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
Other Medical Problems
The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:
- Anuria (cannot pass urine) or
- Hypovolemia (low blood volume), severe or
- Intracranial bleeding, active (except during craniotomy or head surgery) or
- Lung or breathing problems, severe (eg, congestion, fluid or swelling in the lungs)—Should not be used in patients with these conditions.
- Brain problems (eg, compromised blood-brain barrier) or
- Congestive heart failure or
- Kidney disease—Use with caution. May make this condition worse.
- Fluid or electrolyte imbalance—Use with caution. Must be corrected first before receiving this medicine.